ClinicalTrials.gg
RecruitingNCT04197258PARADEUpdated May 25, 2025

Evaluation of the Impact of an Individual Peer Support Intervention for Stroke Patients When Returning Home: a Mixed Methods Pilot Study

An interventional study of Peer support in Stroke, sponsored by Hospices Civils de Lyon. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-25.

Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Oct 2020; still recruiting 6 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 40 studies in Stroke by Hospices Civils de Lyon — 13 open to participants now, 14 under way, none of them phase 3. Stroke · Hospices Civils de Lyon.

Planned enrollment
15th of 26
40 · median 50
Started
2020
the only one that year
No phase
24 of 40
8 open now
Primary completion
2026-12
later than 7 of 13 live
Registered
24th of 40
by date

Among the 40 studies in Stroke by Hospices Civils de Lyon, this one is the 15th largest by planned enrollment of the 26 interventional ones that give a count, is the only one that started in 2020, is one of 24 with no phase, reaches primary completion later than 7 of the 13 other live ones, and was the 24th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

13 of the 40 studies in Stroke by Hospices Civils de Lyon are open now, in 1 country. Recruiting first, the newest first:

7 more — sign in →

By country, each count listing its studies:

All 13 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 40 studies in Stroke by Hospices Civils de Lyon, or all of them as a file.
02

Study summary

Going back home following a stroke is a key step for the patient and his or her relatives. Due to the brutality of stroke and increasingly shorter in-hospital lengths of stay, patients and their families must adapt quickly to the patient's new health functioning and the new caregiving and support role for family members.

Peer support could be an innovative and inexpensive approach to addressing these issues. Peer-helpers are patient-partners who put their experiential knowledge from life with the disease at the disposal of other patients to offer them social and emotional support in the management of the disease in connection with care, social and community structures. Group peer support programs face organizational challenges and fail to address the full range of patient needs for stroke home visits. Individualized and more flexible support could better meet the needs of patients. Our hypothesis is that individual peer support improves quality of life and patient empowerment during the discharge period compared to usual practice.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Stroke
  • Peer support
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patient,
  • Having had a first confirmed, ischemic or hemorrhagic stroke
  • Managed in the participating rehabilitation center
  • Whose discharge to home directly from the rehabilitation center is planned
  • Presenting a modified Rankin score of 1 to 3 when deciding to leave the stroke center
  • Having given its written consent
  • Whose main residence is located in the Rhône department
  • Aphasic patients may be included if a caregiver can follow up with the case manager

Exclusion criteria

Exclusion Criteria:

  • Patient living in an institution prior to stroke
  • included in a gerontological network before stroke
  • Patient unable to understand quality of life questionnaires
  • Patient with unstable medical or psychological conditions who, in the opinion of the investigator, could lead the subject to be non-compliant or uncooperative during the study or could compromise patient safety or participation in the study
  • Patient under guardianship or curatorship
  • Patient not affiliated to a social health insurance
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    intervention group

    For 6 months after discharge, patients in the intervention group will benefit from peer support by a trained patient (number and frequency of contacts defined according to the patient's needs). The intervention aims to improve the patient's ability to manage his or her situation and meet his or her needs upon discharge at home, including identifying and seeking for the necessary health or social resources

    Other: Peer support

  • No intervention
    control group

    Patients included in the control group before intervention will receive the usual practices. As part of the study, they will be contacted for data collection 6 months after the transition to home by a clinical research associate.

Interventions

  • OtherPeer support

    The intervention studied is the psycho-social support by a peer-helper to the patients and their main informal caregiver during the return home following a stay in rehabilitation center for a stroke. Peer support intervention will be based on evidence, Bandura's social learning and social support theory, and the results of our ongoing study of the needs of patients and their caregivers as a result of returning home (Stroke69). It will include a meeting before the discharge and a regular follow-up for 6 months (face-to-face meetings, virtual or by phone), adapted to the needs of the patient and his caregiver, taking into account the social environment and in connection with the devices existing sanitary and social.

06

What researchers measure

Primary outcomes

  1. Feasibility measure

    The feasibility of the intervention will be evaluated as success with a combined criteria including: * Recruitment and training of 2 peer helpers, * Support offered to 20 patients by the peer helpers during the intervention period defined by at least one meeting before and one contact after discharge per patient included in period after, * Good acceptability by patients, carers and peer helpers. These data will be collected by a qualitative approach associating semi-directive interviews, focus groups and participant observation.

    Time frame: 6 months

Secondary outcomes

  1. Quality of life between the discharge from hospital and 6 months

    Evolution of the dimensions of the SIS at hospital discharge and 6 months: force dimension

    Time frame: 6 months

  2. Quality of life between the discharge from hospital and 6 months

    Evolution of the dimensions of the SIS at hospital discharge and 6 months: manual function

    Time frame: 6 months

  3. Quality of life between the discharge from hospital and 6 months

    Evolution of the dimensions of the SIS at hospital discharge and 6 months: AVQ/AVD

    Time frame: 6 months

  4. Quality of life between the discharge from hospital and 6 months

    Evolution of the dimensions of the SIS at hospital discharge and 6 months: Mobility

    Time frame: 6 months

  5. Quality of life between the discharge from hospital and 6 months

    Evolution of the dimensions of the SIS at hospital discharge and 6 months: Communication and Emotions

    Time frame: 6 months

  6. Quality of life between the discharge from hospital and 6 months

    Evolution of the dimensions of the SIS at hospital discharge and 6 months: Memory and thinking

    Time frame: 6 months

  7. Quality of life between the discharge from hospital and 6 months

    Evolution of the dimensions of the SIS at hospital discharge and 6 months: global recovery

    Time frame: 6 months

  8. Anxiety and depression scores between discharge and 6 months

    Evolution of anxiety and depression scores between discharge and 6 months after discharge, measured by the Hospital Anxiety and Depression scale (HADS) score

    Time frame: 6 months

  9. Patient activation Measure

    Evolution of patient activation between discharge and 6 months after discharge, measured by the Patient activation Measure (PAM) score

    Time frame: 6 months

  10. Disability

    proportion of patients with disabilities at 6 months evaluated by the Modified Rankin Scale (no disability corresponding to mRs\<3)

    Time frame: 6 months

  11. Adherence

    proportion of adherent patients at 6 months evaluated by the Medication Adherence Rating Scale (MARS)

    Time frame: 6 months

  12. Human, material and financial assistance provided at home

    Human, material and financial assistance provided at home collected by interviewing the patient

    Time frame: 6 months

  13. Satisfaction measure

    Perceived satisfaction of the support received on during the discharge period will be collected by interviewing the patient

    Time frame: 6 months

  14. Caregiver burden

    Evolution of caregiver burden between discharge and 6 months after discharge, measured by the Zarit burden scale

    Time frame: 6 months

  15. Caregiver satisfaction

    Perceived caregiver satisfaction of the support during the patient's discharge period will be collected by interviewing caregiver

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2020 (actual). Primary completion is estimated for Dec 2026, 73 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 73 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 5, 2019
First posted
Dec 13, 2019
StartActual
Oct 9, 2020
Primary completionEst.
Dec 5, 2026
CompletionEst.
Dec 5, 2026
Last update
May 25, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04197258
Responsible party
Sponsor
First posted
Dec 13, 2019
Start date
Oct 9, 2020
Primary completion
Dec 5, 2026 (estimated)
Completion
Dec 5, 2026 (estimated)
Last update
May 25, 2025

Study contacts

Julie Haesebaert, MD
Contact
julie.haesebaert01@chu-lyon.fr
472684905 ext. +33
Anne Termoz
Contact
anne.termoz@chu-lyon.fr
427856300 ext. +33

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion